Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin. - Wikidata - wikimedia - TriplyDB

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

http://www.wikidata.org/entity/Q34272451

about

Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways.Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications Challenges and recent advances in mass spectrometric imaging of neurotransmitters.ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin Temporal association of elevated cholecystokininergic tone and adolescent trauma is critical for posttraumatic stress disorder-like behavior in adult mice.Ancient Anxiety Pathways Influence Drosophila Defense Behaviors Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects How might circadian rhythms control mood? Let me count the ways...Stress and eating: a dual role for bombesin-like peptides Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.Regulation of aggression by obesity-linked genes TfAP-2 and Twz through octopamine signaling in Drosophila.Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity.Arousal and the attentional network in panic disorder.Local corticotropin releasing hormone (CRH) signals to its receptor CRHR1 during postnatal development of the mouse olfactory bulb.Cholecystokinin-Like Peptide (DSK) in Drosophila, Not Only for Satiety Signaling Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness.

P2860

Q28546379-18C38D82-31B5-4C2F-8F3B-63BD40E23F32 Q31114020-9C524977-835C-4B63-ACB1-A54B45B14475 Q31123604-A89C3EBA-0ADE-4906-B68A-5D3893348C0A Q33717424-FC01333C-86A2-4E35-9099-CC78EB829B43 Q34157765-82B8D5AE-2C13-43EB-B5DA-060EEEB125DD Q35533016-6FB2CAD2-09B5-4FE5-9D58-4A45B335F682 Q36782164-052B72C8-15A0-455D-B33A-C00B6FF9B503 Q36783145-C6B392F9-0899-4504-B661-28FB4E9EC5BC Q37030195-A97CA467-A6DE-45BD-893E-BC33E8FC5594 Q37049794-8DAD3470-4447-404F-B50F-9BDCF1FEFCC2 Q37312345-22BB214C-87E3-43DB-B255-14227C680159 Q37372982-39354C05-8BD1-4922-915A-60979311EDEE Q37412786-987032AB-D13E-41F1-AB55-602299CF3694 Q37686937-545D5D44-007F-482F-83D2-509A7DCF4D1C Q37740010-FE3CE641-EFF7-4051-86CB-770AD3443417 Q38259787-2322B793-781B-4259-B95E-62119CF67333 Q38304170-F6919202-3EA4-4113-A177-D7A5B5EE9224 Q42121384-500398A1-0864-41B9-BF3C-52ECEEAEC82F Q47656495-72D1DB3C-F566-418C-A769-5B55E164BAE8

P2860

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

http://www.wikidata.org/entity/Q34272451

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@ast

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@en

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@nl

type

label

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@ast

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@en

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@nl

prefLabel

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@ast

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@en

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@nl

P1433

Q34272451-3F73AA39-2188-4B74-82F4-754724FD13E5

P1476

Q34272451-6531536A-42DA-4CAB-AA36-6EBE22131933

P2093

Q34272451-5826FE70-77DA-4DA2-B8EA-F28BF856A70D

Q34272451-A55A48E2-3E82-4B9B-9691-26F35A3E64C5

Q34272451-B95DCC4A-82FA-4188-B191-E763544BF716

P2860

Q34272451-0323E510-87EE-4E2F-ABEF-668E6F595171

Q34272451-053A052A-8010-4556-8D9E-44E8F3E73F41

Q34272451-05F4CEDC-88F9-4889-943D-49E18B79EE22

Q34272451-06B3790B-C74A-41E5-A846-01D318B6C2DA

Q34272451-071ED614-97C0-4D8A-AFA0-33342B91C085

Q34272451-0843D00F-1FA5-45C5-ABE6-4352B185D404

Q34272451-08BDD018-38AA-45B2-A5FF-96AF94944D84

Q34272451-0D077015-4C7F-4E3B-BE5E-06BEE4E37D44

Q34272451-0E42EC7B-BB90-4256-834D-6F269E9B71A9

Q34272451-108585A1-8D68-44E6-B973-046FA962715F

P304

Q34272451-052EF1A8-C247-4E67-8526-122049F7CFD8

P31

Q34272451-A4DBB16B-16A2-4FD9-BC05-483CAB147321

P356

Q34272451-5506E964-0FF0-465A-B6D4-FC345E156E15

P433

Q34272451-884F04D5-18ED-4AB4-9F90-490611C8368C

P478

Q34272451-54297E7E-7859-4D84-992E-5EFBDB407219

P577

Q34272451-76F8BC54-2C0B-45C6-B8CF-405ED773AE59

P698

Q34272451-83A8B45C-3511-4F98-A4EE-8ADD3CC03E07

P921

Q34272451-E5E31FF4-1707-45BE-8C94-E74A823E6924

P356

P1433

Depression and Anxiety

P1476

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

@en

P2093

J Bradwejn

http://www.w3.org/2001/XMLSchema#string

K Domschke

http://www.w3.org/2001/XMLSchema#string

P Zwanzger

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin

Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse

Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

Characterization of mice lacking the gene for cholecystokinin.

Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.

P304

762-774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DA.21919

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22553078

http://www.w3.org/2001/XMLSchema#string

P921

Cholecystokinin